StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2024 - 03 - 25
7
2024 - 01 - 08
7
2024 - 01 - 04
7
2023 - 12 - 04
8
2023 - 11 - 28
8
2023 - 10 - 24
7
2023 - 09 - 20
7
2023 - 09 - 14
7
2023 - 09 - 05
7
2023 - 08 - 15
7
2022 - 12 - 06
7
2022 - 10 - 20
8
2022 - 10 - 11
8
2022 - 05 - 19
9
2022 - 04 - 12
9
2022 - 03 - 29
9
2022 - 03 - 22
7
2022 - 03 - 02
9
2022 - 01 - 25
11
2022 - 01 - 11
11
2022 - 01 - 05
12
2022 - 01 - 04
7
2021 - 12 - 16
7
2021 - 11 - 09
9
2021 - 10 - 26
7
2021 - 10 - 25
8
2021 - 10 - 18
8
2021 - 10 - 13
8
2021 - 10 - 12
7
2021 - 09 - 28
12
2021 - 09 - 27
7
2021 - 09 - 23
7
2021 - 09 - 21
9
2021 - 09 - 13
10
2021 - 09 - 08
9
2021 - 08 - 02
7
2021 - 07 - 15
7
2021 - 07 - 08
8
2021 - 07 - 06
7
2021 - 06 - 29
8
2021 - 06 - 24
8
2021 - 06 - 23
7
2021 - 06 - 17
8
2021 - 06 - 10
11
2021 - 06 - 02
7
2021 - 05 - 25
7
2021 - 05 - 06
9
2021 - 04 - 27
9
2021 - 04 - 13
8
2021 - 04 - 12
6
2021 - 04 - 07
8
2021 - 03 - 22
7
2021 - 03 - 16
6
2021 - 03 - 01
6
2021 - 02 - 02
6
2021 - 02 - 01
7
2021 - 01 - 19
8
2021 - 01 - 12
7
2021 - 01 - 05
6
2020 - 12 - 17
6
Sector
Communications
1
Health technology
5
Manufacturing
1
Technology services
2
Tags
Acquisition
3
Automotive
5
Biopharma
3
Biotech-bay
5
Biotech-beach
5
Biotechnology
3
Cancer
11
China
3
Clinical-trials-phase-iii
4
Collaboration
8
Commercialization
4
Communication
3
Conference
44
Contract
3
Covid
8
Designation
3
Device
5
Disease
7
Distribution
4
Drug
5
Earnings
15
Ema
9
Energy
10
Europe
8
Eye
4
Fda
6
Financial report
3
Financial results
33
Food
5
Genomic
3
Growing
3
Growth
14
India
3
Injection
3
Iot
6
Liver
7
Market
8
Media
6
Merge
7
Money
4
N/a
335
Offering
17
Phase 1
7
Phase 2
6
Phase 3
7
Positive
8
Pre-clinical
4
Preclinical
4
Presentation
7
Research
20
Results
61
Security
4
Set
4
Technology
7
Test
4
Therapy
5
Topline
6
Treatment
11
Trial
18
Vaccine
6
Entities
Astrazeneca plc
1
Biogen inc.
1
Bristol-myers squibb company
1
Centurylink, inc. d/b/a lumen technologies, inc.
1
Cisco systems, inc.
1
Duck creek technologies, inc.
1
Evaxion biotech a/s - adr
1
Marinus pharmaceuticals, inc.
1
Tcr2 therapeutics inc.
1
Ultragenyx pharmaceutical inc.
1
Xeris pharmaceuticals, inc.
1
Symbols
AZN
1
BIIB
1
BMY
1
CSCO
1
DCT
1
EVAX
1
LUMN
1
MRNS
1
RARE
1
TCRR
1
XERS
1
Exchanges
Nasdaq
8
Nyse
2
Crawled Date
2021 - 10 - 25
8
Crawled Time
07:00
1
10:00
1
11:00
1
12:00
2
13:00
2
14:15
1
Source
www.biospace.com
4
www.duckcreek.com
1
www.globenewswire.com
2
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 10 - 25
tags :
Collaboration
save search
Loulou Foundation Announces Launch of Pre-Competitive Industry Collaboration for CDKL5 Deficiency Disorder Observational Study
Published:
2021-10-25
(Crawled : 14:15)
- biospace.com/
RARE
F
|
$43.38
-1.65%
-1.68%
770K
|
Health Technology
|
-43.61%
|
O:
-0.18%
H:
3.13%
C:
2.06%
BIIB
|
$190.52
-0.85%
-0.84%
1.3M
|
Health Technology
|
-26.3%
|
O:
0.45%
H:
2.07%
C:
1.48%
collaboration
Second Clinical Trial Collaboration Initiated to Evaluate Datopotamab Deruxtecan in Combination with KEYTRUDA® (pembrolizumab) in Patients with Metastatic Non-Small Cell Lung Cancer
Published:
2021-10-25
(Crawled : 13:00)
- biospace.com/
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
10.34%
|
O:
0.11%
H:
0.03%
C:
-0.27%
lung cancer
collaboration
cancer
trial
initiated
keytruda
Marinus Pharmaceuticals Joins the Loulou Foundation in Collaboration on CANDID, a Comprehensive Observational Study in CDKL5 Deficiency Disorder
Published:
2021-10-25
(Crawled : 13:00)
- biospace.com/
MRNS
|
$1.41
-2.08%
-2.13%
4.6M
|
Health Technology
|
-87.3%
|
O:
-0.18%
H:
4.6%
C:
1.99%
collaboration
Lumen and Cisco expand their partnership to help businesses embrace the future of work with advanced communication and collaboration solutions
Published:
2021-10-25
(Crawled : 12:00)
- prnewswire.com
LUMN
|
$1.32
1.52%
6M
|
Communications
|
-89.44%
|
O:
-0.48%
H:
0.0%
C:
-1.77%
CSCO
|
News
|
$48.11
0.67%
0.64%
10M
|
Technology Services
|
-13.24%
|
O:
-0.88%
H:
0.55%
C:
0.05%
partnership
collaboration
communication
Xeris Pharmaceuticals Enters Collaboration Agreement With Merck
Published:
2021-10-25
(Crawled : 12:00)
- biospace.com/
XERS
|
$1.76
-1.12%
-0.56%
1.1M
|
Health Technology
|
-7.37%
|
O:
13.16%
H:
0.0%
C:
-10.7%
collaboration
TCR² Therapeutics Announces Clinical Trial Collaboration Agreement with Bristol Myers Squibb to Evaluate Gavo-cel in Combination with Opdivo® and Yervoy® in Mesothelin-Expressing Solid Tumors
Published:
2021-10-25
(Crawled : 11:00)
- globenewswire.com
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
-16.38%
|
O:
-0.08%
H:
0.77%
C:
0.16%
TCRR
4
|
$1.48
3.38%
3.9M
|
Health Technology
|
-78.36%
|
O:
-0.88%
H:
1.92%
C:
0.88%
solid tumors
collaboration
trial
cel
Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma
Published:
2021-10-25
(Crawled : 10:00)
- globenewswire.com
EVAX
|
$4.22
2.68%
2.38%
35K
|
Manufacturing
|
Email alert
Add to watchlist
biotech
collaboration
iot
keytruda
DUCK CREEK ANNOUNCES NEW COLLABORATIVE AGREEMENT WITH TIREA FOCUSED ON THE SPECIALTY MARKET
Published:
2021-10-25
(Crawled : 07:00)
- duckcreek.com
DCT
|
$18.99
0.0%
0
|
Technology Services
|
-40.58%
|
O:
0.84%
H:
1.24%
C:
-1.8%
collaboration
Gainers vs Losers
59%
41%
Top 10 Gainers
AGBA
|
News
|
$1.03
157.5%
57.94%
120M
|
Finance
ZCMD
|
$1.45
5.84%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.52
100.0%
51.13%
5M
|
Health Technology
ISPC
|
$0.421
97.65%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.5
45.65%
470K
|
OST
|
$0.509
23.81%
45.26%
90K
|
GDHG
|
$0.263
21.76%
40.66%
3.1M
|
XPON
|
News
|
$3.15
63.21%
37.74%
16M
|
TIRX
|
$0.8
65.02%
30.74%
58M
|
BNTC
|
News
|
$6.82
42.08%
30.64%
3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.